InfoLawGroup Insights

Issues to consider in allocating your budgetRegulators and legislators have signaled that there are some key privacy and advertising issues to be sure to get right this coming year.  To help you allocate your legal/compliance budget, we asked our team “What is one legal issue (or to do item) to prioritize in 2025?”  Here are

by: Mindy Abern and John AllaireOn December 19, 2024, the Food and Drug Administration (“FDA”) announced a final rule updating the definition of the term “healthy” and comparable words (e.g., “healthful,” “healthiest,” and “healthiness”) to help consumers identify foods that are that are consistent with dietary recommendations. Manufacturers can voluntarily use the term “healthy”

by: Max LandawIn November, Missouri voters did not just go to the polls to elect the next president.  They also voted narrowly to pass Amendment 2 to the state constitution, which legalized sports wagering (including online sports wagering) and directed the Missouri Gaming Commission to make such sports wagering available by December 1, 2025.The

by: Justine Young Gottshall and Sophia Allen

Today, we are discussing Maryland’s “Kids Code” (effective Oct. 1, 2024), Connecticut’s amendment to the CDPA that addresses minor data (effective Oct. 1, 2024), and parts of the California’s Age-Appropriate Design Code Act (“CAADCA”) (effective July 1, 2024). In case you missed it: In August, the Ninth Circuit

by: Chloé NelsonIn today’s digital landscape, nearly all businesses rely on website tracking technologies to gather insight and optimize online experiences. However, as data privacy concerns continue to rise, businesses must take a closer look at the tracking technologies embedded in their websites. Regulators from coast to coast are issuing warnings and guidance on

by: Foram DmytrykEverything is bigger in Texas, including expectations related to AI tools. On September 18, the Lone Star State entered a petition of assurance of voluntary compliance with Dallas based artificial intelligence (“AI”) technology company, Pieces Technologies Inc. Piece’s generative AI products purported to summarize, chart and draft clinical notes meant to be